GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioporto AS (OCSE:BIOPOR) » Definitions » Total Inventories

Bioporto AS (OCSE:BIOPOR) Total Inventories : kr4.64 Mil (As of Dec. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Bioporto AS Total Inventories?

Bioporto AS's total inventories for the quarter that ended in Dec. 2024 was kr4.64 Mil. Bioporto AS's average total inventories from the quarter that ended in Sep. 2024 to the quarter that ended in Dec. 2024 was kr4.68 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Bioporto AS's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was kr0.09.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Bioporto AS's Days Inventory for the three months ended in Dec. 2024 was 101.61.

Inventory Turnover measures how fast the company turns over its inventory within a year. Bioporto AS's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.90.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Bioporto AS's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.59.


Bioporto AS Total Inventories Historical Data

The historical data trend for Bioporto AS's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioporto AS Total Inventories Chart

Bioporto AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.17 2.72 2.56 3.79 4.64

Bioporto AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.79 3.27 4.29 4.72 4.64

Bioporto AS Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Bioporto AS  (OCSE:BIOPOR) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Bioporto AS's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is

Net-Net Working Capital Per Share (Q: Dec. 2024 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(59.664+0.75 * 8.187+0.5 * 4.64-28.234
-0-0)/429.657
=0.09

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Bioporto AS's Days Inventory for the three months ended in Dec. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2024 )/Cost of Goods Sold (Q: Dec. 2024 )*Days in Period
=4.679/4.202*365 / 4
=101.61

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Bioporto AS's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2024 ) / Average Total Inventories (Q: Dec. 2024 )
=4.202 / 4.679
=0.90

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Bioporto AS's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=4.679 / 7.897
=0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Bioporto AS Total Inventories Related Terms

Thank you for viewing the detailed overview of Bioporto AS's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioporto AS Business Description

Traded in Other Exchanges
Address
Tuborg Havnevej 15, Ground Floor, Hellerup, DNK, DK-2900
Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America.

Bioporto AS Headlines

No Headlines